Group 1 - Longsheng Technology's stock price increased by 5.03% on September 17, reaching 65.13 CNY per share, with a trading volume of 1.324 billion CNY and a turnover rate of 12.10%, resulting in a total market capitalization of 14.831 billion CNY [1] - The stock has risen for four consecutive days, with a cumulative increase of 30.93% during this period [1] - Longsheng Technology, established on June 16, 2004, and listed on July 25, 2017, operates in the engine exhaust gas recirculation (EGR) systems, new energy, and precision components sectors, with revenue composition of 62.71% from other segments and 37.29% from EGR products and injection systems [1] Group 2 - According to data from the top ten holdings of funds, one fund under the Fortune Fund has a significant position in Longsheng Technology [2] - The Fortune New Materials New Energy Mixed A Fund (009092) reduced its holdings by 754,100 shares in the second quarter, retaining 729,500 shares, which accounts for 2.5% of the fund's net value, ranking as the tenth largest holding [2] - The fund has achieved a year-to-date return of 66.3%, ranking 362 out of 8,172 in its category, and a one-year return of 124.93%, ranking 225 out of 7,980 [2]

Core Insights - Despite the active performance of sectors like technology, new consumption, and pharmaceuticals, investors have found it challenging to achieve ideal returns, with the CSI 300 index showing a mere 0.03% increase year-to-date as of June, contrasting sharply with the nearly 8% rise in the Wind Active Equity Mixed Fund Index, highlighting the scarcity of professional research capabilities in volatile markets [1] Group 1: Fund Performance - In Q2, public funds achieved a total profit of 386.3 billion yuan, with Fuqun Fund ranking fifth in the industry with a profit of 19.492 billion yuan. For the first half of the year, Fuqun Fund generated 29.832 billion yuan for investors, placing it fourth overall [2] - Fuqun Fund's active equity research strength is a core competitive advantage, with 11 of its equity funds ranking in the top 10 of their categories over the past year. Notably, Fuqun Medical Innovation Stock A and Fuqun Active Growth One-Year Regular Open Mixed Fund both exceeded 40% in returns [2][3] Group 2: Long-term Performance - Over the past five and seven years, Fuqun Fund has had 5 and 10 products, respectively, ranking in the top 10 of their categories. Fuqun New Vitality Flexible Allocation Mixed A achieved returns of 67.84% and 175.32% over the past five and seven years, respectively, ranking first in its category [4] - Fuqun Global Consumer Selection A, managed by a Hong Kong fund manager, has shown impressive long-term performance with returns of 86.16% and 70.68% over the past two and three years [3] Group 3: Fixed Income and Quantitative Strategies - In the fixed income sector, Fuqun Fund's products have maintained a "steady" approach despite market challenges. Fuqun Strong Return Regular Open Bond A achieved returns of 13.03%, 23.28%, and 45.09% over three, five, and seven years, respectively, ranking in the top 9% of its category [5] - Fuqun Fund's quantitative strategies have also performed well, with 10 of its quantitative funds ranking in the top 10 of their categories over the past year. The classic broad-based ETF, the Shanghai Composite Index ETF, has consistently ranked in the top 5 over three, five, and seven years [6]